Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 18,822 | 22,596 | 21,651 | 19,392 | 19,192 |
| Operating Income | -18,822 | -22,596 | -21,651 | -19,392 | -19,192 |
| Other Income | 3,033 | 2,659 | 2,357 | 2,052 | 1,488 |
| Pre-tax Income | -15,789 | -19,937 | -19,294 | -17,340 | -17,704 |
| Net Income Continuous | -15,789 | -19,937 | -19,294 | -17,340 | -17,704 |
| Net Income | $-15,789 | $-19,937 | $-19,294 | $-17,340 | $-17,704 |
| EPS Basic Total Ops | -0.28 | -0.36 | -0.35 | -0.31 | -0.32 |
| EPS Basic Continuous Ops | -0.28 | -0.36 | -0.35 | -0.31 | -0.32 |
| EPS Diluted Total Ops | -0.28 | -0.36 | -0.35 | -0.31 | -0.32 |
| EPS Diluted Continuous Ops | -0.28 | -0.36 | -0.35 | -0.31 | -0.32 |
| EBITDA(a) | $-20,394 | $-23,860 | $-22,664 | $-20,167 | $-19,542 |